|Articles|May 1, 2003
Onychomycosis Alternative
Author(s)Suzette Hill
San Francisco - The key to effectively treating toenail and fingernail onychomycosis may lay in the delivery system rather than in the drug itself, according to preliminary results of an open-label feasibility study of a 4 percent clotrimazole lacquer formulated with the drug delivery technology CPE-215 (15 percent).
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Updates iPLEDGE REMS with New Modifications for Pregnancy Testing and Prescription Windows
2
Targeting MRGPRX2: Early Human Data for a Novel CSU Approach
3
Precision Medicine Arrives in Atopic Dermatitis: Guiding Systemic Treatment Decisions Through Gene Expression Profiling
4
Phase 3 Results Signal a New Era for Oral Targeted Therapy in Psoriasis
5